✦ LIBER ✦

An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma

✍ Scribed by Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 359 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940201)73:3<688::aid-cncr2820730330>3.0.co;2-v

No coin nor oath required. For personal study only.

✦ Synopsis

Background.

Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.

📜 SIMILAR VOLUMES

Phase II trial of trimetrexate for patie

Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287)

✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast

Taxol in advanced, hormone-refractory ca

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

✍ Bruce J. Roth; Patrick J. Loehrer; Beow Yong Yeap; George Wilding; Basil Kasimis 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

A randomized Phase II trial of echinomyc

A randomized Phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma : An Eastern Cooperative Oncology Group Study (E1587)

✍ Alex Y. Chang; KyungMann Kim; Hélène Boucher; Philip Bonomi; James A. Stewart; D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: Patients with metastatic nonsmall cell lung carcinoma (nsclc) usually have a poor prognosis. a chemotherapy regimen containing cisplatin is commonly used for symptom palliation. echinomycin is a potent bifunctional intercalator of double-strand dna; trimetrexate is a new derivative o

Final report of a phase II evaluation of

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)

✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Vinblastine, ifosfamide, and gallium nit

Vinblastine, ifosfamide, and gallium nitrate—an active new regimen in patients with advanced carcinoma of the urothelium : A Phase II trial of the Eastern Cooperative Oncology Group (E5892)

✍ Robert Dreicer; Kathleen J. Propert; Bruce J. Roth; Lawrence H. Einhorn; Patrick 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

vinblastine, ifosfamide, and gallium nitrate (VIG) as first-line chemotherapy in patients with locally advanced or metastatic carcinoma of the

A Phase II trial of cisplatin plus WR-27

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma : An Eastern Cooperative Oncology Group Study (E8188)

✍ William J. Gradishar; Patricia Stephenson; Donna J. Glover; Donna S. Neuberg; Me 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views